A. , H. George, T. Vm, K. , S. et al., Arteriovenous malformation after transradial percutaneous coronary intervention, Indian Heart J, vol.60, p.64, 2008.

S. D. Abbot, M. Rowe, K. Cadwallader, A. Ricksten, J. Gordon et al., Epstein-Barr virus nuclear antigen 2 induces expression of the virusencoded latent membrane protein, J. Virol, vol.64, pp.2126-2134, 1990.

L. V. Abruzzo, K. Schmidt, L. M. Weiss, E. S. Jaffe, L. J. Medeiros et al., B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus, Blood, vol.82, pp.241-246, 1993.

A. Adams and T. Lindahl, Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells, Proc. Natl. Acad. Sci. U. S. A, vol.72, pp.1477-1481, 1975.

H. K. Adldinger, H. Delius, U. K. Freese, J. Clarke, and G. W. Bornkamm, A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes, Virology, vol.141, pp.221-234, 1985.

R. H. Advani, F. Hong, S. J. Horning, B. S. Kahl, J. Manola et al., Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial, Leuk. Lymphoma, vol.53, pp.718-720, 2012.

R. H. Advani, S. M. Ansell, M. J. Lechowicz, A. W. Beaven, F. Loberiza et al., A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T-cell consortium trial, Br. J. Haematol, vol.172, pp.535-544, 2016.

C. Agostinelli, P. P. Piccaluga, P. Went, M. Rossi, A. Gazzola et al., Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies, J. Clin. Pathol, vol.61, pp.1160-1167, 2008.

A. Tabaa, Y. Tuaillon, E. Bollore, K. Foulongne, V. Petitjean et al., Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells, Blood, vol.113, pp.604-611, 2009.

S. M. Alam, P. J. Travers, J. L. Wung, W. Nasholds, S. Redpath et al., T-cell-receptor affinity and thymocyte positive selection, Nature, vol.381, pp.616-620, 1996.

M. Albanese, T. Tagawa, M. Bouvet, L. Maliqi, D. Lutter et al., Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells, Proc. Natl. Acad. Sci. U. S. A, vol.113, pp.6467-6475, 2016.

C. Alfieri, M. Birkenbach, and E. Kieff, Early events in Epstein-Barr virus infection of human B lymphocytes, Virology, vol.181, pp.595-608, 1991.

C. Alfieri, J. Tanner, L. Carpentier, C. Perpête, A. Savoie et al., Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx, Blood, vol.87, pp.812-817, 1996.

M. J. Allday, D. H. Crawford, G. , and B. E. , Epstein-Barr virus latent gene expression during the initiation of B cell immortalization, J. Gen. Virol, vol.70, pp.1755-1764, 1989.

M. J. Allday, Q. Bazot, and R. E. White, The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells, Curr. Top. Microbiol. Immunol, vol.391, pp.61-117, 2015.

M. Altmann, D. Pich, R. Ruiss, J. Wang, B. Sugden et al., Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.14188-14193, 2006.

G. B. Ambepitiya, Angioimmunoblastic lymphadenopathy associated with thyroid disease, J. Clin. Pathol, vol.42, pp.668-669, 1989.

R. F. Ambinder, W. A. Shah, D. R. Rawlins, G. S. Hayward, H. et al., Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA, J. Virol, vol.64, pp.2369-2379, 1990.

M. R. Ambrosio, M. Navari, L. Di-lisio, E. A. Leon, A. Onnis et al., The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma, Infect. Agent. Cancer, vol.9, p.12, 2014.

F. Amore, T. Relander, G. F. Lauritzsen, E. Jantunen, H. Hagberg et al., Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.30, pp.3093-3099, 2012.

I. Anagnostopoulos, M. Hummel, T. Finn, M. Tiemann, P. Korbjuhn et al., Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type, Blood, vol.80, pp.1804-1812, 1992.

E. Anderton, J. Yee, P. Smith, T. Crook, R. E. White et al., Two EpsteinBarr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumoursuppressor Bim: clues to the pathogenesis of Burkitt's lymphoma, Oncogene, vol.27, pp.421-433, 2008.

K. Aozasa, T. Takakuwa, and S. Nakatsuka, Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation, Adv. Anat. Pathol, vol.12, pp.324-331, 2005.

P. L. Aronson, C. Thurm, E. R. Alpern, E. A. Alessandrini, D. J. Williams et al., Variation in care of the febrile young infant <90 days in US pediatric emergency departments, Pediatrics, vol.134, pp.667-677, 2014.

J. R. Arrand, R. , and L. , Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells, J. Virol, vol.41, pp.376-389, 1982.

M. S. Arredouani, M. K. Bhasin, D. R. Sage, L. K. Dunn, M. B. Gill et al., Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection, J. Virol, vol.88, pp.5559-5577, 2014.

S. Artavanis-tsakonas, K. Matsuno, and M. E. Fortini, Notch signaling, Science, vol.268, pp.225-232, 1995.

A. D. Attygalle, T. C. Diss, P. Munson, P. G. Isaacson, M. Q. Du et al., CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma, Am. J. Surg. Pathol, vol.28, pp.54-61, 2004.

W. Au, D. D. Weisenburger, T. Intragumtornchai, S. Nakamura, W. Kim et al., Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project, and International Peripheral T-Cell Lymphoma Project, vol.113, pp.3931-3937, 2009.

S. Aviel, G. Winberg, M. Massucci, C. , and A. , Degradation of the epsteinbarr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue, J. Biol. Chem, vol.275, pp.23491-23499, 2000.

G. J. Babcock, L. L. Decker, M. Volk, and D. A. Thorley-lawson, EBV persistence in memory B cells in vivo, Immunity, vol.9, pp.395-404, 1998.

G. J. Babcock, L. L. Decker, R. B. Freeman, and D. A. Thorley-lawson, Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients, J. Exp. Med, vol.190, pp.567-576, 1999.

R. Baer, A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell et al., DNA sequence and expression of the B95-8 Epstein-Barr virus genome, Nature, vol.310, pp.207-211, 1984.

B. G. Bajaj, M. Murakami, Q. Cai, S. C. Verma, K. Lan et al., EpsteinBarr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein, J. Virol, vol.82, pp.4082-4090, 2008.

A. S. Banerjee, A. D. Pal, and S. Banerjee, Epstein-Barr virus-encoded small noncoding RNAs induce cancer cell chemoresistance and migration, Virology, vol.443, pp.294-305, 2013.
DOI : 10.1016/j.virol.2013.05.020
URL : https://doi.org/10.1016/j.virol.2013.05.020

A. Banko, I. Lazarevic, M. Cupic, G. Stevanovic, I. Boricic et al., Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients, J. Med. Virol, vol.84, pp.632-642, 2012.

S. Barth, T. Pfuhl, A. Mamiani, C. Ehses, K. Roemer et al., Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5, Nucleic Acids Res, vol.36, pp.666-675, 2008.

J. Van-beek, A. A. Brink, M. B. Vervoort, M. J. Van-zijp, C. J. Meijer et al., , 2003.

T. Cheng, S. Hsieh, W. Hsu, Y. Chen, H. Ho et al., Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity, Int. J. Oncol, vol.36, pp.151-160, 2010.

A. K. Chiang, Q. Tao, G. Srivastava, and F. C. Ho, Nasal NK-and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease, Int. J. Cancer, vol.68, pp.285-290, 1996.

C. Chim, E. S. Ma, F. Loong, and Y. Kwong, Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for EpsteinBarr virus encoded early small RNA in detecting occult bone marrow involvement, J. Clin. Pathol, vol.58, pp.443-445, 2005.

E. Y. Choy, K. Siu, K. Kok, R. W. Lung, C. M. Tsang et al., An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival, J. Exp. Med, vol.205, pp.2551-2560, 2008.

W. F. Coffin, K. D. Erickson, M. Hoedt-miller, M. , and J. M. , The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain, Oncogene, vol.20, pp.5313-5330, 2001.

J. I. Cohen, F. Wang, J. Mannick, and E. Kieff, Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation, Proc. Natl. Acad. Sci. U. S. A, vol.86, pp.9558-9562, 1989.

J. I. Cohen, L. Dropulic, A. P. Hsu, C. S. Zerbe, T. Krogmann et al., Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.63, pp.41-47, 2016.

M. Cordier, A. Calender, M. Billaud, U. Zimber, G. Rousselet et al., Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23, J. Virol, vol.64, pp.1002-1013, 1990.

L. Couronné, C. Bastard, and O. A. Bernard, TET2 and DNMT3A mutations in human T-cell lymphoma, N. Engl. J. Med, vol.366, pp.95-96, 2012.

B. R. Cullen, Herpesvirus microRNAs: phenotypes and functions, Curr. Opin. Virol, vol.1, pp.211-215, 2011.
DOI : 10.1016/j.coviro.2011.04.003
URL : http://europepmc.org/articles/pmc3171754?pdf=render

T. Dambaugh, C. Beisel, M. Hummel, W. King, S. Fennewald et al., Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping, Proc. Natl. Acad. Sci. U. S. A, vol.77, pp.2999-3003, 1980.
DOI : 10.1073/pnas.77.5.2999
URL : http://www.pnas.org/content/77/5/2999.full.pdf

V. Dardalhon, A. Awasthi, H. Kwon, G. Galileos, W. Gao et al., IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells, Nat. Immunol, vol.9, pp.1347-1355, 2008.

C. W. Dawson, R. J. Port, Y. , and L. S. , The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC), Semin. Cancer Biol, vol.22, pp.144-153, 2012.

E. M. Deacon, G. Pallesen, G. Niedobitek, J. Crocker, L. Brooks et al., Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells, J. Exp. Med, vol.177, pp.339-349, 1993.

G. Del-prete, Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy, Allergy, vol.47, pp.450-455, 1992.

H. J. Delecluse, I. Anagnostopoulos, F. Dallenbach, M. Hummel, T. Marafioti et al., Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection, Blood, vol.89, pp.1413-1420, 1997.

M. Delfau-larue, L. De-leval, B. Joly, A. Plonquet, D. Challine et al., Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA, Haematologica, vol.97, pp.1594-1602, 2012.

O. Devergne, E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen et al., Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation, Mol. Cell. Biol, vol.16, pp.7098-7108, 1996.

V. R. Dharnidharka, Peripheral Blood Epstein-Barr Viral Nucleic Acid Surveillance as a Marker for Posttransplant Cancer Risk, Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg, vol.17, pp.611-616, 2017.

J. Dheekollu, K. Malecka, A. Wiedmer, H. Delecluse, A. K. Chiang et al., Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency, Oncotarget, vol.8, pp.7248-7264, 2017.

J. J. Van-dongen, A. W. Langerak, M. Brüggemann, P. Evans, .. S. Hummel et al., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and Tcell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936, Leukemia, vol.17, pp.2257-2317, 2003.

H. Y. Draoua, L. Tsao, D. M. Mancini, L. J. Addonizio, G. Bhagat et al., T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience, Br. J. Haematol, vol.127, pp.429-432, 2004.

K. Dunleavy, W. H. Wilson, J. , and E. S. , Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications, Curr. Opin. Hematol, vol.14, pp.348-353, 2007.
DOI : 10.1097/moh.0b013e328186ffbf

J. Dupuis, K. Boye, N. Martin, C. Copie-bergman, A. Plonquet et al., Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells, Am. J. Surg. Pathol, vol.30, pp.490-494, 2006.

G. Frizzera, E. M. Moran, R. , and H. , Angio-immunoblastic lymphadenopathy with dysproteinaemia, Lancet Lond. Engl, vol.1, pp.1070-1073, 1974.

G. Frizzera, E. M. Moran, R. , and H. , Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course, Am. J. Med, vol.59, pp.803-818, 1975.

M. Fukuda and R. Longnecker, Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation, J. Virol, vol.79, pp.8655-8660, 2005.

M. Fukuda and R. Longnecker, Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway, J. Virol, vol.81, pp.9299-9306, 2007.

N. Fukushima, T. Satoh, M. Sano, O. ;. Tokunaga, J. Kline et al., Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma, G 125. Galanina, vol.42, pp.81-90, 2001.

A. Gallamini, F. Zaja, C. Patti, A. Billio, M. R. Specchia et al., Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial, Blood, vol.110, pp.2316-2323, 2007.

K. Ganjoo, F. Hong, S. J. Horning, R. D. Gascoyne, Y. Natkunam et al., Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404), Leuk. Lymphoma, vol.55, pp.768-772, 2014.

J. Garibal, E. Hollville, A. I. Bell, G. L. Kelly, B. Renouf et al., Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A, J. Virol, vol.81, pp.7598-7607, 2007.

P. Gaulard and L. De-leval, The microenvironment in T-cell lymphomas: emerging themes, Semin. Cancer Biol, vol.24, pp.49-60, 2014.
DOI : 10.1016/j.semcancer.2013.11.004

P. Gerper, J. Whang-peng, M. , and J. H. , Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures, Proc. Natl. Acad. Sci. U. S. A, vol.63, pp.740-747, 1969.

O. Gires, F. Kohlhuber, E. Kilger, M. Baumann, A. Kieser et al., DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus, J. Virol, vol.18, pp.524-542, 1978.

S. L. Glaser, R. J. Lin, S. L. Stewart, R. F. Ambinder, R. F. Jarrett et al., Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data, Int. J. Cancer, vol.70, pp.375-382, 1997.
DOI : 10.1002/(sici)1097-0215(19970207)70:4<375::aid-ijc1>3.0.co;2-t
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/%28SICI%291097-0215%2819970207%2970%3A4%3C375%3A%3AAID-IJC1%3E3.0.CO%3B2-T

J. N. Glickman, J. G. Howe, and J. A. Steitz, Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells, J. Virol, vol.62, pp.902-911, 1988.

A. Gloghini, R. Dolcetti, and A. Carbone, Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology, Semin. Cancer Biol, vol.23, pp.457-467, 2013.
DOI : 10.1016/j.semcancer.2013.08.004

E. Gödde-salz, A. C. Feller, and K. Lennert, Chromosomal abnormalities in lymphogranulomatosis X (LgrX)/angioimmunoblastic lymphadenopathy (AILD), Leuk. Res, vol.11, pp.181-190, 1987.

D. I. Godfrey, J. Kennedy, T. Suda, A. ;. Zlotnik, C. Wang et al., Pillars article: a developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression, Gong, vol.150, pp.255-262, 1950.

, Comment on: Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, Haematologica, vol.101, pp.269-270

J. Gosselin, J. Menezes, M. D&apos;addario, J. Hiscott, L. Flamand et al., Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus, Eur. J. Immunol, vol.21, pp.203-208, 1991.
DOI : 10.1002/eji.1830210130

S. Gottschalk, C. M. Rooney, and H. E. Heslop, Post-transplant lymphoproliferative disorders, Annu. Rev. Med, vol.56, pp.29-44, 2005.

L. Gradoville, D. Kwa, A. El-guindy, and G. Miller, Protein kinase Cindependent activation of the Epstein-Barr virus lytic cycle, J. Virol, vol.76, pp.5612-5626, 2002.
DOI : 10.1128/jvi.76.11.5612-5626.2002
URL : https://jvi.asm.org/content/76/11/5612.full.pdf

J. S. Greenspan, G. , and D. , Oral hairy leukoplakia: diagnosis and management. Oral Surg, Oral Med. Oral Pathol, vol.67, pp.396-403, 1989.
DOI : 10.1016/0030-4220(89)90381-2

R. J. Greenwald, G. J. Freeman, and A. H. Sharpe, The B7 family revisited, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115611

, Annu. Rev. Immunol, vol.23, pp.515-548

N. Greifenegger, M. Jäger, L. A. Kunz-schughart, H. Wolf, and F. Schwarzmann,

. Epstein-barr, virus small RNA (EBER) genes: differential regulation during lytic viral replication, J. Virol, vol.72, pp.9323-9328

E. Grogan, H. Jenson, J. Countryman, L. Heston, L. Gradoville et al., , 1987.

, Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells, Proc. Natl. Acad. Sci. U. S. A, vol.84, pp.1332-1336

K. L. Grogg, A. D. Attygalle, A. D. Attygale, W. R. Macon, E. D. Remstein et al., Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral Tcell lymphoma, unspecified, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.19, pp.1101-1107, 2006.

H. Groux, F. Cottrez, C. Montpellier, B. Quatannens, J. Coll et al.,

C. Auriault, Isolation and characterization of transformed human T-cell lines infected by Epstein-Barr virus, Blood, vol.89, pp.4521-4530, 1997.

A. A. Gru, B. H. Haverkos, A. G. Freud, J. Hastings, N. B. Nowacki et al., The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment, Curr. Hematol. Malig. Rep, vol.10, pp.456-467, 2015.

B. Gruhne, R. Sompallae, D. Marescotti, S. A. Kamranvar, S. Gastaldello et al., The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.2313-2318, 2009.

A. T. Grundhoff, E. Kremmer, O. Türeci, A. Glieden, C. Gindorf et al., Characterization of DP103, a novel DEAD box protein that binds to the Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C, J. Biol. Chem, vol.274, pp.19136-19144, 1999.

E. Grywalska, R. , and J. , Epstein-Barr virus-associated lymphomas, 2015.

, Semin. Oncol, vol.42, pp.291-303

P. Gunvén, G. Klein, G. Henle, W. Henle, C. et al., Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus, Nature, vol.228, pp.427-433, 1970.

W. Hammerschmidt and B. Sugden, Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes, Nature, vol.340, pp.393-397, 1989.

S. Harada and E. Kieff, Epstein-Barr virus nuclear protein LP stimulates EBNA2 acidic domain-mediated transcriptional activation, J. Virol, vol.71, pp.6611-6618, 1997.

C. Harold, D. Cox, R. , and K. J. , Epstein-Barr viral microRNAs target caspase, 2016.
DOI : 10.1186/s12985-016-0602-7
URL : https://virologyj.biomedcentral.com/track/pdf/10.1186/s12985-016-0602-7

, Virol. J, vol.13, p.145

N. L. Harris, E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan et al., , 1994.

M. Higuchi, K. M. Izumi, and E. Kieff, Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.4675-4680, 2001.

M. Higuchi, E. Kieff, and K. M. Izumi, The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines, J. Virol, vol.76, pp.455-459, 2002.

A. Hildesheim, W. , and C. , Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors, Semin. Cancer Biol, vol.22, pp.107-116, 2012.

M. M. Hitt, M. J. Allday, T. Hara, L. Karran, M. D. Jones et al., EBV gene expression in an NPC-related tumour, EMBO J, vol.8, pp.2639-2651, 1989.

H. Hjalgrim, J. Friborg, M. , and M. , The epidemiology of EBV and its association with malignant disease, Human Herpesviruses: Biology, Therapy, 2007.

D. Hochberg, T. Souza, M. Catalina, J. L. Sullivan, K. Luzuriaga et al., Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells, J. Virol, vol.78, pp.5194-5204, 2004.

L. Holmgren, A. Szeles, E. Rajnavölgyi, J. Folkman, G. Klein et al., Horizontal transfer of DNA by the uptake of apoptotic bodies, Blood, vol.93, pp.3956-3963, 1999.

C. Hömig-hölzel, C. Hojer, J. Rastelli, S. Casola, L. J. Strobl et al., Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis, J. Exp. Med, vol.205, pp.1317-1329, 2008.

G. C. Horvath and W. H. Schubach, Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain, Biochem. Biophys. Res. Commun, vol.191, pp.196-200, 1993.

S. M. Horwitz, A. D. Zelenetz, L. I. Gordon, W. G. Wierda, J. S. Abramson et al., NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3, J. Natl. Compr. Cancer Netw. JNCCN, vol.14, pp.1067-1079, 2016.

Y. Hoshino, T. Morishima, H. Kimura, K. Nishikawa, T. Tsurumi et al., Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection, J. Immunol. Baltim. Md, vol.163, pp.5735-5740, 1950.

J. G. Howe and M. D. Shu, Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs, J. Virol, vol.62, pp.2790-2798, 1988.

S. M. Hsu, J. A. Waldron, L. Fink, C. King, S. S. Xie et al., Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathytype T-cell lymphoma, Hum. Pathol, vol.24, pp.126-131, 1993.

L. Hu, B. Troyanovsky, X. Zhang, P. Trivedi, I. Ernberg et al., , 2000.

, Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by EpsteinBarr virus genomes derived from LMP1-positive and-negative nasopharyngeal carcinoma, Cancer Res, vol.60, pp.5589-5593

J. Huang, P. Zhang, Y. Gao, and L. Qiu, Sequential development of diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma, Diagn. Cytopathol, vol.40, pp.346-351, 2012.

D. S. Huen, S. A. Henderson, D. Croom-carter, R. , and M. , The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain, Oncogene, vol.10, pp.549-560, 1995.

M. Hummel, D. Thorley-lawson, and E. Kieff, An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200), J. Virol, vol.49, pp.413-417, 1984.

A. R. Huppmann, M. R. Roullet, M. Raffeld, J. , and E. S. , , 2013.

, Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, pp.28-30

J. L. Huret, S. Senon, A. Bernheim, and P. Dessen, An Atlas on genes and chromosomes in oncology and haematology, Cell. Mol. Biol. Noisy-Gd. Fr, vol.50, pp.805-807, 2004.

I. A. Hutchings, R. J. Tierney, G. L. Kelly, J. Stylianou, A. B. Rickinson et al., Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines, J. Virol, vol.80, pp.10700-10711, 2006.

T. Angioimmunoblastic and . Lymphoma, Crit. Rev. Oncol. Hematol, vol.68, pp.264-271

H. Iiaza, B. Wulff, N. R. Alla, M. Maragkakis, M. Megraw et al., Editing of Epstein-Barr virusencoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency, J. Biol. Chem, vol.285, pp.33358-33370, 2010.

R. Incrocci, M. Mccormack, and M. Swanson-mungerson, Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas, J. Gen. Virol, vol.94, pp.1127-1133, 2013.
DOI : 10.1099/vir.0.049221-0
URL : http://jgv.microbiologyresearch.org/deliver/fulltext/jgv/94/5/1127_vir049221.pdf?itemId=/content/journal/jgv/10.1099/vir.0.049221-0&mimeType=pdf&isFastTrackArticle=

J. Iqbal, D. D. Weisenburger, T. C. Greiner, J. M. Vose, T. Mckeithan et al., Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma, Blood, vol.115, pp.1026-1036, 2010.

Y. Isobe, K. Sugimoto, L. Yang, K. Tamayose, M. Egashira et al., Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells, Cancer Res, vol.64, pp.2167-2174, 2004.

Y. Isobe, K. Sugimoto, I. Matsuura, K. Takada, and K. Oshimi, Epstein-Barr virus renders the infected natural killer cell line, NKL resistant to doxorubicin-induced apoptosis, Br. J. Cancer, vol.99, pp.1816-1822, 2008.

I. I. Ivanov, B. S. Mckenzie, L. Zhou, C. E. Tadokoro, A. Lepelley et al., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells, Cancers, vol.126, pp.1615-1630, 2006.

D. Iwakiri and K. Takada, Role of EBERs in the pathogenesis of EBV infection, Adv. Cancer Res, vol.107, pp.119-136, 2010.

D. Iwakiri, Y. Eizuru, M. Tokunaga, and K. Takada, Autocrine growth of, 2003.

. Epstein-barr, virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA, Cancer Res, vol.63, pp.7062-7067

K. M. Izumi, K. M. Kaye, and E. D. Kieff, Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation, J. Virol, vol.68, pp.4369-4376, 1994.

K. M. Izumi, K. M. Kaye, and E. D. Kieff, Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation, J. Virol, vol.68, pp.4369-4376, 1994.

K. M. Izumi, K. M. Kaye, and E. D. Kieff, The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.1447-1452, 1997.

K. M. Izumi, E. D. Cahir-mcfarland, A. T. Ting, E. A. Riley, B. Seed et al., The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation, Hematol. Am. Soc. Hematol. Educ. Program, vol.19, pp.317-322, 1999.

E. S. Jaffe, The 2008 WHO classification of lymphomas: implications for clinical practice and translational research, Hematol. Am. Soc. Hematol. Educ. Program, pp.523-531, 2009.

E. S. Jaffe, W. , and W. H. , Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications, Cancer Surv, vol.30, pp.233-248, 1997.

M. K. Jenkins, A. Khoruts, E. Ingulli, D. L. Mueller, S. J. Mcsorley et al., In vivo activation of antigen-specific CD4 T cells, Annu. Rev. Immunol, vol.19, pp.23-45, 2001.

E. Johannsen, C. L. Miller, S. R. Grossman, and E. Kieff, EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virustransformed B lymphocytes, J. Virol, vol.70, pp.4179-4183, 1996.

E. Johannsen, M. Luftig, M. R. Chase, S. Weicksel, E. Cahir-mcfarland et al., Proteins of purified Epstein-Barr virus, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.16286-16291, 2004.

L. M. Johansen, C. D. Deppmann, K. D. Erickson, W. F. Coffin, T. M. Thornton et al., EBNA2 and activated Notch induce expression of BATF, J. Virol, vol.77, pp.6029-6040, 2003.

C. H. Jones, S. D. Hayward, and D. R. Rawlins, Interaction of the lymphocytederived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites, J. Virol, vol.63, pp.101-110, 1989.

Y. Jung, H. Choi, H. Kim, and S. K. Lee, MicroRNA miR-BART20-5p stabilizes Epstein-Barr latency by directly targeting BZLF1 and BRLF1, J. Virol, vol.88, pp.9027-9037, 2014.

S. A. Kamranvar and M. G. Masucci, The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress, Leukemia, vol.25, pp.1017-1025, 2011.

H. Kanegane, A. Yachie, T. Miyawaki, and G. Tosato, EBV-NK cells interactions and lymphoproliferative disorders, Leuk. Lymphoma, vol.29, pp.491-498, 1998.

T. Kaneko, J. Fukuda, T. Yoshihara, H. Zheng, S. Mori et al., Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells, Br. J. Haematol, vol.91, pp.355-361, 1995.

Y. Kaneko, R. A. Larson, D. Variakojis, J. M. Haren, and J. D. Rowley, , 1982.

, Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy, Blood, vol.60, pp.877-887

M. Kang and E. Kieff, Epstein-Barr virus latent genes, Exp. Mol. Med, vol.47, p.131, 2015.

L. Karran, Y. Gao, P. R. Smith, G. , and B. E. , Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells, Proc. Natl. Acad. Sci. U. S. A, vol.89, pp.8058-8062, 1992.

Y. Kasahara, Y. , and A. , Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection, Crit. Rev. Oncol. Hematol, vol.44, pp.283-294, 2002.

E. Kashuba, K. Mattsson, K. Pokrovskaja, C. Kiss, M. Protopopova et al., EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells, Int. J. Cancer, vol.105, pp.644-653, 2003.

K. Kato, A. Yokoyama, Y. Tohya, H. Akashi, Y. Nishiyama et al., , 2003.

, Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function, J. Gen. Virol, vol.84, pp.3381-3392

K. M. Kaye, K. M. Izumi, and E. Kieff, Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation, Proc. Natl. Acad. Sci. U. S. A, vol.90, pp.9150-9154, 1993.

A. Kaykas and B. Sugden, The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation, Oncogene, vol.19, pp.1400-1410, 2000.

G. Kelly, A. Bell, R. , and A. , Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2, Nat. Med, vol.8, pp.1098-1104, 2002.

G. L. Kelly, A. E. Milner, R. J. Tierney, D. S. Croom-carter, M. Altmann et al., Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A,-3B, and-3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis, J. Virol, vol.79, pp.10709-10717, 2005.

G. Kennedy and B. Sugden, EBNA-1, a bifunctional transcriptional activator, 2003.

, Mol. Cell. Biol, vol.23, pp.6901-6908

G. Kennedy, J. Komano, and B. Sugden, Epstein-Barr virus provides a survival factor to Burkitt's lymphomas, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.14269-14274, 2003.

S. C. Kenney and J. E. Mertz, Regulation of the latent-lytic switch in EpsteinBarr virus, Semin. Cancer Biol, vol.26, pp.60-68, 2014.

H. Kikuta, Y. Taguchi, K. Tomizawa, K. Kojima, N. Kawamura et al., Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease, Nature, vol.333, pp.455-457, 1988.

E. Kilger, A. Kieser, M. Baumann, and W. Hammerschmidt, Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor, EMBO J, vol.17, pp.1700-1709, 1998.

C. H. Kim, L. M. Pelus, J. R. White, and H. E. Broxmeyer, Differential chemotactic behavior of developing T cells in response to thymic chemokines, Blood, vol.91, pp.4434-4443, 1998.

J. G. Kim, S. K. Sohn, Y. S. Chae, Y. Y. Cho, D. H. Yang et al., Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study, Cancer Chemother. Pharmacol, vol.60, pp.129-134, 2007.

J. H. Kim, W. S. Kim, J. Y. Hong, K. J. Ryu, S. J. Kim et al., Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4mediated activation of NF-?B and Btk, Oncotarget, vol.8, pp.5361-5370, 2017.

N. Kitagawa, M. Goto, K. Kurozumi, S. Maruo, M. Fukayama et al., Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction, EMBO J, vol.19, pp.6742-6750, 2000.

O. Klinke, R. Feederle, and H. Delecluse, Genetics of Epstein-Barr virus microRNAs, Semin. Cancer Biol, vol.26, pp.52-59, 2014.

H. Knecht, E. Bachmann, P. Brousset, K. Sandvej, D. Nadal et al., Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma, Blood, vol.82, pp.2937-2942, 1993.

Y. Ko, EBV and human cancer, Exp. Mol. Med, vol.47, p.130, 2015.

J. Komano, S. Maruo, K. Kurozumi, T. Oda, and K. Takada, Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata, J. Virol, vol.73, pp.9827-9831, 1999.

K. Konstantinou, K. Yamamoto, F. Ishibashi, Y. Mizoguchi, M. Kurata et al., Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma, Br. J. Haematol, vol.144, pp.696-704, 2009.

R. Küppers, B cells under influence: transformation of B cells by Epstein-Barr virus, Nat. Rev. Immunol, vol.3, pp.801-812, 2003.

R. Küppers, Molecular biology of Hodgkin lymphoma, Hematol. Am. Soc. Hematol. Educ. Program, pp.491-496, 2009.

T. Kurosaki, K. Kometani, and W. Ise, Memory B cells, Nat. Rev. Immunol, vol.15, pp.149-159, 2015.

M. Kuzembayeva, M. Hayes, and B. Sugden, Multiple functions are mediated by the miRNAs of Epstein-Barr virus, Curr. Opin. Virol, vol.7, pp.61-65, 2014.

Y. Kwong, Natural killer-cell malignancies: diagnosis and treatment, Leukemia, vol.19, pp.2186-2194, 2005.

C. Kyriakou, C. Canals, A. Goldstone, D. Caballero, B. Metzner et al., High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, pp.218-224, 2007.

P. Presse-medicale and . Fr, , vol.36, pp.1655-1662, 1983.

C. D. Laherty, H. M. Hu, A. W. Opipari, F. Wang, and V. M. Dixit, The EpsteinBarr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B, J. Biol. Chem, vol.267, pp.24157-24160, 1992.

L. L. Laichalk, D. A. Thorley-lawson, B. Larochelle, L. Flamand, P. Gourde et al., Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo, J. Virol, vol.79, pp.1296-1307, 1998.

. Epstein-barr, virus infects and induces apoptosis in human neutrophils, Blood, vol.92, pp.291-299

J. M. Lee, K. Lee, M. Weidner, B. A. Osborne, H. et al., EpsteinBarr virus EBNA2 blocks Nur77-mediated apoptosis, Proc. Natl. Acad. Sci. U. S. A, vol.99, pp.11878-11883, 2002.
DOI : 10.1073/pnas.182552499
URL : http://www.pnas.org/content/99/18/11878.full.pdf

N. Lee, J. Harris, A. S. Garden, W. Straube, B. Glisson et al., Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.27, pp.3684-3690, 2009.
DOI : 10.1200/jco.2008.19.9109
URL : http://europepmc.org/articles/pmc2720082?pdf=render

S. H. Lee, J. S. Kim, J. Kim, S. J. Kim, W. S. Kim et al., , 2015.

, A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients, Haematologica, vol.100, pp.505-507

S. Lee, T. Rüdiger, T. Odenwald, S. Roth, P. Starostik et al.,

, Angioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4, Int. J. Cancer, vol.103, pp.12-20

E. R. Leight and B. Sugden, EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus, Rev. Med. Virol, vol.10, pp.83-100, 2000.

F. Lemonnier, L. Couronné, M. Parrens, J. Jaïs, M. Travert et al., Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters, Blood, vol.120, pp.1466-1469, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00752170

K. Lennert, , 1979.

, Dtsch. Med. Wochenschr, vol.104, pp.1246-1247, 1946.

D. Lenze, L. Leoncini, M. Hummel, S. Volinia, C. G. Liu et al., The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma, Leukemia, vol.25, pp.1869-1876, 2011.

S. Lepretre, G. Buchonnet, A. Stamatoullas, P. Lenain, C. Duval et al., Chromosome abnormalities in peripheral T-cell lymphoma, Cancer Genet. Cytogenet, vol.117, pp.71-79, 2000.

E. Lindhout, A. Lakeman, M. L. Mevissen, and C. De-groot, Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines, J. Exp. Med, vol.179, pp.1173-1184, 1994.
DOI : 10.1084/jem.179.4.1173
URL : http://jem.rupress.org/content/179/4/1173.full.pdf

P. D. Ling, J. J. Hsieh, I. K. Ruf, D. R. Rawlins, H. et al., EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1, J. Virol, vol.68, pp.5375-5383, 1994.

P. D. Ling, R. S. Peng, A. Nakajima, J. H. Yu, J. Tan et al., Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100, EMBO J, vol.24, pp.3565-3575, 2005.

M. A. Linterman, L. Beaton, D. Yu, R. R. Ramiscal, M. Srivastava et al., IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses, J. Exp. Med, vol.207, pp.353-363, 2010.

E. H. Lipford, H. R. Smith, S. Pittaluga, E. S. Jaffe, A. D. Steinberg et al., Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma, J. Clin. Invest, vol.79, pp.637-642, 1987.

P. Liu, X. Fang, Z. Feng, Y. Guo, R. Peng et al., Direct sequencing and characterization of a clinical isolate of EpsteinBarr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology, J. Virol, vol.85, pp.11291-11299, 2011.

Y. M. Lo, Prognostic implication of pretreatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinoma, Biomed. Pharmacother. Biomedecine Pharmacother, vol.55, pp.362-365, 2001.

A. K. Lo, K. F. To, K. W. Lo, R. W. Lung, J. W. Hui et al., Modulation of LMP1 protein expression by EBV-encoded microRNAs, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.16164-16169, 2007.

K. W. Lo, K. F. To, and D. P. Huang, Focus on nasopharyngeal carcinoma, Cancer Cell, vol.5, pp.423-428, 2004.

C. Lome-maldonado, D. Canioni, O. Hermine, E. Delabesse, D. Damotte et al., Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL?, Leukemia, vol.16, pp.2134-2141, 2002.

H. M. Long, T. A. Haigh, N. H. Gudgeon, A. M. Leen, C. Tsang et al., CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines, J. Virol, vol.79, pp.4896-4907, 2005.

R. Longnecker, Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?, Adv. Cancer Res, vol.79, pp.175-200, 2000.

J. Lu, M. Murakami, S. C. Verma, Q. Cai, S. Haldar et al., , 2011.

Y. Mao, M. P. Lu, H. Lin, D. W. Zhang, Y. Liu et al., Prognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studies, PloS One, vol.8, p.60313, 2013.

T. Marafioti, J. C. Paterson, E. Ballabio, A. Chott, Y. Natkunam et al., The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation, Haematologica, vol.95, pp.432-439, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00477518

A. R. Marquitz and N. Raab-traub, The role of miRNAs and EBV BARTs in NPC, 2012.

, Semin. Cancer Biol, vol.22, pp.166-172

A. R. Marquitz, A. Mathur, R. H. Edwards, and N. Raab-traub, Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region, J. Virol, vol.89, pp.11256-11268, 2015.

P. Martel, L. Laroche, P. Courville, C. Larroche, J. Wechsler et al., Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis, Arch. Dermatol, vol.136, pp.881-886, 2000.

T. Matsuo, M. Heller, L. Petti, E. O&apos;shiro, and E. Kieff, Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA, Science, vol.226, pp.1322-1325, 1984.

K. A. Mcaulay, C. D. Higgins, K. F. Macsween, A. Lake, R. F. Jarrett et al., HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection, J. Clin. Invest, vol.117, pp.3042-3048, 2007.

K. L. Mcclain, C. T. Leach, H. B. Jenson, V. V. Joshi, B. H. Pollock et al., Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS, N. Engl. J. Med, vol.332, pp.12-18, 1995.

L. J. Mcheyzer-williams, N. Pelletier, L. Mark, N. Fazilleau, and M. ,

M. G. , Follicular helper T cells as cognate regulators of B cell immunity, Curr. Opin. Immunol, vol.21, pp.266-273, 2009.

E. A. Mesri, M. A. Feitelson, and K. Munger, Human viral oncogenesis: a cancer hallmarks analysis, Cell Host Microbe, vol.15, pp.266-282, 2014.

M. C. Meyohas, V. Maréchal, N. Desire, J. Bouillie, J. Frottier et al., Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs, J. Virol, vol.70, pp.6816-6819, 1996.

G. Miller, The oncogenicity of Epstein-Barr virus, J. Infect. Dis, vol.130, pp.187-205, 1974.

N. Miller and L. M. Hutt-fletcher, Epstein-Barr virus enters B cells and epithelial cells by different routes, J. Virol, vol.66, pp.3409-3414, 1992.

G. Miller, T. Shope, H. Lisco, D. Stitt, and M. Lipman, Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes, Proc. Natl. Acad. Sci. U. S. A, vol.69, pp.383-387, 1972.

W. E. Miller, R. H. Edwards, D. M. Walling, and N. Raab-traub, Sequence variation in the Epstein-Barr virus latent membrane protein 1, J. Gen. Virol, vol.75, pp.2729-2740, 1994.

E. M. Miyashita, B. Yang, G. J. Babcock, and D. A. Thorley-lawson, , 1997.

, Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell, J. Virol, vol.71, pp.4882-4891

S. J. Molesworth, C. M. Lake, C. M. Borza, S. M. Turk, and L. M. Hutt-fletcher, , 2000.

. Epstein-barr, virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells, J. Virol, vol.74, pp.6324-6332

P. Mombaerts, J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa et al., RAG-1-deficient mice have no mature B and T lymphocytes, Cell, vol.68, pp.869-877, 1992.

C. Montpellier, P. Crepieux, B. Quatannens, B. Delobel, M. Croquette et al., Homologous T and B cells immortalized in vitro by the Epstein-Barr virus exhibit differential genetical and functional features, Int. J. Oncol, vol.11, pp.87-96, 1997.

M. A. Morris, C. W. Dawson, L. Laverick, A. M. Davis, J. P. Dudman et al., The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGF? and ?1 integrin signalling, Sci. Rep, vol.6, 2016.

G. Mosialos, M. Birkenbach, R. Yalamanchili, T. Vanarsdale, C. Ware et al., The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family, Cell, vol.80, pp.389-399, 1995.

W. N. Moss, N. Lee, G. Pimienta, and J. A. Steitz, RNA families in Epstein-Barr virus, RNA Biol, vol.11, pp.10-17, 2014.

N. Mourad, N. Mounier, J. Brière, E. Raffoux, A. Delmer et al.,

J. Emile, R. Bouabdallah, and A. Bosly, Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials, Blood, vol.111, pp.4463-4470, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00282621

N. E. Mueller, E. T. Lennette, K. Dupnik, and B. M. Birmann, Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis, Int. J. Cancer, vol.130, pp.2886-2891, 2012.

S. Murono, T. Yoshizaki, H. Sato, H. Takeshita, M. Furukawa et al.,

N. Mutalima, E. Molyneux, H. Jaffe, S. Kamiza, E. Borgstein et al., Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study, PloS One, vol.3, pp.2505-324, 2008.

H. Nagoshi, J. Kuroda, T. Kobayashi, S. Maegawa, Y. Chinen et al., Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis, Int. J. Hematol, vol.98, pp.366-374, 2013.

H. Nakagomi, R. Dolcetti, M. T. Bejarano, P. Pisa, R. Kiessling et al., The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines, Int. J. Cancer, vol.57, pp.240-244, 1994.

T. Nakayama, K. Hieshima, D. Nagakubo, E. Sato, M. Nakayama et al.,

O. Yoshie, A. Nanbo, K. Inoue, K. Adachi-takasawa, and K. Takada, Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus, J. Virol, vol.78, pp.954-965, 2002.

B. N. Nathwani, H. Rappaport, E. M. Moran, G. A. Pangalis, K. et al., , 1978.

M. Nelson, D. E. Horsman, D. D. Weisenburger, R. D. Gascoyne, B. J. Dave et al., Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma, Malignant lymphoma arising in angioimmunoblastic lymphadenopathy, vol.41, pp.461-469, 2008.

A. Nicolae, S. Pittaluga, G. Venkataraman, A. Vijnovich-baron, L. Xi et al., Peripheral T-cell lymphomas of follicular T-helper cell derivation with, 2013.

. Hodgkin/reed, Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist, Am. J. Surg. Pathol, vol.37, pp.816-826

G. Niedobitek, A. Agathanggelou, M. Rowe, E. L. Jones, D. B. Jones et al., Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma, Blood, vol.86, pp.659-665, 1995.

M. Niens, R. F. Jarrett, B. Hepkema, I. M. Nolte, A. Diepstra et al., HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma, Blood, vol.110, pp.3310-3315, 2007.

D. Niino, Y. Komohara, T. Murayama, R. Aoki, Y. Kimura et al., Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic, 2010.

, Pathol. Int, vol.60, pp.278-283

J. Nishikawa, H. Yoshiyama, H. Iizasa, Y. Kanehiro, M. Nakamura et al., Epstein-barr virus in gastric carcinoma, Cancers, vol.6, pp.2259-2274, 2014.

F. Nitsche, A. Bell, R. , and A. , Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain, J. Virol, vol.71, pp.6619-6628, 1997.

O. Odejide, O. Weigert, A. A. Lane, D. Toscano, M. A. Lunning et al.,

D. Bodegom, S. Bolla, and J. H. Schatz, A targeted mutational landscape of angioimmunoblastic T-cell lymphoma, Blood, vol.123, pp.1293-1296, 2014.

M. Ohashi, A. M. Holthaus, M. A. Calderwood, C. Lai, B. Krastins et al., The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth, PLoS Pathog, vol.11, p.1004822, 2015.

S. Ohshima-kharaoka, J. Suzumiya, C. Kawasaki, M. Kanda, and M. Kikuchi, , 2000.

, Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia, Leuk. Lymphoma, vol.38, pp.541-545

E. P. Ontiveros, A. Halwani, L. L. Stunz, N. Kamberos, A. K. Olivier et al., A new model of LMP1-MYC interaction in B cell lymphoma, Leuk. Lymphoma, vol.55, pp.2917-2923, 2014.

O. Shea, J. J. , P. , and W. E. , Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells, Science, vol.327, pp.1098-1102, 2010.

W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, and S. G. Hymowitz, Regulation and functions of the IL-10 family of cytokines in inflammation and disease, Annu. Rev. Immunol, vol.29, pp.71-109, 2011.

T. J. Owen, J. D. O&apos;neil, C. W. Dawson, C. Hu, X. Chen et al.,

L. E. Mitchell, R. J. White, and L. S. Young, Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBERassociated cellular transcription factors, Mol. Cancer, vol.9, p.241, 2010.

T. Oyama, K. Yamamoto, N. Asano, A. Oshiro, R. Suzuki et al., Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.13, pp.5124-5132, 2007.

A. Perez-garcia, Z. Carpenter, F. Abate, M. Allegretta, and J. E. Haydu, Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas, Nat. Genet, vol.46, pp.166-170, 2014.

A. L. Palser, N. E. Grayson, R. E. White, C. Corton, S. Correia et al., Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection, J. Virol, vol.89, pp.5222-5237, 2015.
DOI : 10.1128/jvi.03614-14
URL : https://jvi.asm.org/content/89/10/5222.full.pdf

J. Pandya, D. M. Walling, and R. Watkins, Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase, J. Virol, vol.80, pp.4752-4760, 1997.

, Clin. Otolaryngol. Allied Sci, vol.26, pp.3-8

J. H. Park, S. Y. Na, Y. J. Lee, E. W. Cho, K. et al., Downregulation of MHC class II expression by oxidant-induced apoptosis in EBV-transformed B-cells, Mol. Cells, vol.10, pp.654-661, 2000.

S. Park, J. Lee, Y. H. Ko, A. Han, H. J. Jun et al., The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma, Blood, vol.110, pp.972-978, 2007.

G. A. Parker, R. Touitou, A. , and M. J. , Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis, Oncogene, vol.19, pp.700-709, 2000.
DOI : 10.1038/sj.onc.1203327
URL : https://www.nature.com/articles/1203327.pdf

J. Parsonnet, S. Hansen, L. Rodriguez, A. B. Gelb, R. A. Warnke et al., Helicobacter pylori infection and gastric lymphoma, N. Engl. J. Med, vol.330, pp.1267-1271, 1994.

R. L. Patterson, D. B. Van-rossum, R. K. Barrow, and S. H. Snyder, RACK1 binds to inositol 1,4,5-trisphosphate receptors and mediates Ca2+ release, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.2328-2332, 2004.
DOI : 10.1073/pnas.0308567100
URL : http://www.pnas.org/content/101/8/2328.full.pdf

P. Pautier, A. Devidas, A. Delmer, H. Dombret, L. Sutton et al., Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature, Leuk. Lymphoma, vol.32, pp.545-552, 1999.

R. Peng, S. C. Moses, J. Tan, E. Kremmer, L. et al., The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter, J. Virol, vol.79, pp.4492-4505, 2005.

J. J. Peschon, P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell, E. Maraskovsky et al., Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice, J. Exp. Med, vol.180, pp.1955-1960, 1994.
DOI : 10.1084/jem.180.5.1955
URL : http://jem.rupress.org/content/180/5/1955.full.pdf

S. Pfeffer, M. Zavolan, F. A. Grässer, M. Chien, J. J. Russo et al., Identification of virus-encoded microRNAs, Science, vol.304, pp.734-736, 2004.
DOI : 10.1126/science.1096781

P. P. Piccaluga, C. Agostinelli, A. Califano, A. Carbone, L. Fantoni et al., Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation, Cancer Res, vol.67, pp.10703-10710, 2007.
DOI : 10.1158/0008-5472.can-07-1708
URL : http://cancerres.aacrjournals.org/content/67/22/10703.full.pdf

P. P. Piccaluga, M. Navari, G. De-falco, M. R. Ambrosio, S. Lazzi et al., Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas, Oncotarget, vol.7, pp.224-240, 2015.

P. A. Pizzo, I. T. Magrath, S. K. Chattopadhyay, R. J. Biggar, and P. Gerber, A new tumour-derived transforming strain of Epstein-Barr virus, Nature, vol.272, pp.629-631, 1978.

G. Pizzolo, F. Vinante, C. Agostini, R. Zambello, L. Trentin et al., Immunologic abnormalities in angioimmunoblastic lymphadenopathy, Cancer, vol.60, pp.2412-2418, 1987.
DOI : 10.1002/1097-0142(19871115)60:10<2412::aid-cncr2820601010>3.0.co;2-f
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/1097-0142%2819871115%2960%3A10%3C2412%3A%3AAID-CNCR2820601010%3E3.0.CO%3B2-F

J. H. Pope, M. K. Horne, and W. Scott, Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus, Int. J. Cancer, vol.3, pp.857-866, 1968.

A. Puel, S. Cypowyj, J. Bustamante, J. F. Wright, L. Liu et al., Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity, Science, vol.332, pp.65-68, 2011.

A. Puls, A. G. Eliopoulos, C. D. Nobes, T. Bridges, L. S. Young et al., , 1999.

, Activation of the small GTPase Cdc42 by the inflammatory cytokines TNF(alpha) and IL-1, and by the Epstein-Barr virus transforming protein LMP1, J. Cell Sci, vol.112, pp.2983-2992

C. Quivoron, L. Couronné, V. Della-valle, C. K. Lopez, I. Plo et al., TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis, Cancer Cell, vol.20, pp.25-38, 2011.

J. Qiu and D. A. Thorley-lawson, EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.431-441, 2002.

N. Raab-traub, F. , and K. , The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation, Cell, vol.47, pp.883-889, 1986.

N. Raab-traub, P. Rajadurai, K. Flynn, and A. P. Lanier, Epstein-Barr virus infection in carcinoma of the salivary gland, J. Virol, vol.65, pp.7032-7036, 1991.

M. Rabson, L. Gradoville, L. Heston, and G. Miller, Non-immortalizing P3J, 1982.

. Hr-1, Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J. Virol, vol.44, pp.834-844

S. A. Radkov, R. Touitou, A. Brehm, M. Rowe, M. West et al., Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription, J. Virol, vol.73, pp.5688-5697, 1999.

F. Radtke, A. Wilson, G. Stark, M. Bauer, J. Van-meerwijk et al.,

M. Aguet, Deficient T cell fate specification in mice with an induced inactivation of Notch1, Immunity, vol.10, pp.547-558, 1999.

T. Ragoczy, L. Heston, and G. Miller, The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes, J. Virol, vol.72, pp.7978-7984, 1998.

D. R. Rawlins, G. Milman, S. D. Hayward, H. , and G. S. , Sequencespecific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region, Cell, vol.42, pp.859-868, 1985.

M. P. Rechsteiner, C. Berger, L. Zauner, J. A. Sigrist, M. Weber et al., Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infection, J. Virol, vol.82, pp.1739-1747, 2008.

H. J. Ree, M. E. Kadin, M. Kikuchi, Y. H. Ko, J. Suzumiya et al., Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic Tcell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma, Hum. Pathol, vol.30, pp.403-411, 1999.

D. Reisman and B. Sugden, trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1, Mol. Cell. Biol, vol.6, pp.3838-3846, 1986.

M. E. Ressing, M. Van-gent, A. M. Gram, M. J. Hooykaas, S. J. Piersma et al., Immune Evasion by Epstein-Barr Virus, Curr. Top. Microbiol. Immunol, vol.391, pp.355-381, 2015.

R. P. Revoltella, E. Vigneti, A. Fruscalzo, M. Park, G. Ragona et al., Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell lines established from the bone marrow of children with maturation defects of haematopoiesis, J. Gen. Virol, vol.70, pp.1203-1215, 1989.

A. B. Rickinson, Co-infections, inflammation and oncogenesis: future directions for EBV research, Semin. Cancer Biol, vol.26, pp.99-115, 2014.

A. B. Rickinson, L. S. Young, R. , and M. , Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells, J. Virol, vol.61, pp.1310-1317, 1987.

A. B. Rickinson, H. M. Long, U. Palendira, C. Münz, and A. D. Hislop, Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory, Trends Immunol, vol.35, pp.159-169, 2014.

E. S. Robertson, B. Tomkinson, and E. Kieff, An Epstein-Barr virus with a 58kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro, J. Virol, vol.68, pp.1449-1458, 1994.

E. S. Robertson, S. Grossman, E. Johannsen, C. Miller, J. Lin et al., Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa, J. Virol, vol.69, pp.3108-3116, 1995.

E. S. Robertson, J. Lin, E. Kieff, H. Rogatsch, H. Bonatti et al., Epstein-Barr virus-associated multicentric leiomyosarcoma in an adult patient after heart transplantation: case report and review of the literature, Am. J. Surg. Pathol, vol.70, pp.614-621, 1996.

J. Rohr, S. Guo, J. Huo, A. Bouska, C. Lachel et al., Recurrent activating mutations of CD28 in peripheral T-cell lymphomas, Leukemia, vol.30, pp.1062-1070, 2016.

G. Roncador, G. Verdes-montenegro, J. Tedoldi, S. Paterson, J. C. Klapper et al., Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma, Haematologica, vol.92, pp.1059-1066, 2007.

M. D. Rosa, E. Gottlieb, M. R. Lerner, and J. A. Steitz, Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirusassociated ribonucleic acids VAI and VAII, Mol. Cell. Biol, vol.1, pp.785-796, 1981.

M. Roschewski, W. , and W. H. , EBV-associated lymphomas in adults, Best Pract. Res. Clin. Haematol, vol.25, pp.75-89, 2012.

M. Rowe, L. S. Young, K. Cadwallader, L. Petti, E. Kieff et al., , 1989.

, Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins, J. Virol, vol.63, pp.1031-1039

L. Rymo, Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells, J. Virol, vol.32, pp.8-18, 1979.

R. H. Sadler and N. Raab-traub, Structural analyses of the Epstein-Barr virus BamHI A transcripts, J. Virol, vol.69, pp.1132-1141, 1995.

A. Saha and E. S. Robertson, Epstein-Barr virus Associated B-cell lymphomas: Pathogenesis and Clinical Outcomes, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.17, pp.3056-3063, 2011.

A. Saha, M. Murakami, P. Kumar, B. Bajaj, K. Sims et al., , 2009.

. Epstein-barr, virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2, J. Virol, vol.83, pp.4652-4669

C. Saint-ruf, K. Ungewiss, M. Groettrup, L. Bruno, H. J. Fehling et al., Analysis and expression of a cloned pre-T cell receptor gene, J. Immunol. Baltim. Md, vol.266, pp.5165-5169, 1950.
URL : https://hal.archives-ouvertes.fr/inserm-02177273

M. Saito, T. Fukuda, T. Shiohara, and M. Homori, Angioimmunoblastic T-cell lymphoma: a relatively common type of T-cell lymphoma in Sjögren's syndrome, Clin. Exp. Rheumatol, vol.23, pp.888-890, 2005.

K. Sakamoto, T. Sekizuka, T. Uehara, T. Hishima, S. Mine et al., Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas, Cancer Med, vol.6, pp.605-618, 2017.

M. Sakata-yanagimoto, T. Enami, K. Yoshida, Y. Shiraishi, R. Ishii et al., Somatic RHOA mutation in angioimmunoblastic T cell lymphoma, Nat. Genet, vol.46, pp.171-175, 2014.

M. Samanta, D. Iwakiri, and K. Takada, Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling, Oncogene, vol.27, pp.4150-4160, 2008.

J. Sample, L. Young, B. Martin, T. Chatman, E. Kieff et al.,

. Epstein-barr, virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes, J. Virol, vol.64, pp.4084-4092

J. Sample, L. Brooks, C. Sample, L. Young, M. Rowe et al., Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site, Proc. Natl. Acad. Sci. U. S. A, vol.88, pp.6343-6347, 1991.

F. Sato, T. Ishida, A. Ito, F. Mori, A. Masaki et al., Angioimmunoblastic T-cell lymphoma mice model, Leuk. Res, vol.37, pp.21-27, 2013.

M. Savard, C. Bélanger, M. Tardif, P. Gourde, L. Flamand et al., Infection of primary human monocytes by Epstein-Barr virus, J. Virol, vol.74, pp.2612-2619, 2000.

B. C. Schaefer, J. L. Strominger, and S. H. Speck, Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines, Proc. Natl. Acad. Sci. U. S. A, vol.92, pp.10565-10569, 1995.

B. C. Schaefer, J. L. Strominger, and S. H. Speck, The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines, J. Virol, vol.69, pp.5039-5047, 1995.

B. C. Schaefer, J. L. Strominger, and S. H. Speck, Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs, Mol. Cell. Biol, vol.17, pp.364-377, 1997.

R. Scheenstra, E. Verschuuren, .. M. De-haan, A. Slooff, M. J. The et al., The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients, Transpl. Infect. Dis. Off. J. Transplant. Soc, vol.6, pp.15-22, 2004.

B. Schlegelberger, Y. Zhang, K. Weber-matthiesen, G. , and W. , Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics, Blood, vol.84, pp.2640-2648, 1994.

R. Schmitz, M. Ceribelli, S. Pittaluga, G. Wright, and L. M. Staudt, Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb, 2014.

H. W. Schroeder, C. , and L. , Structure and function of immunoglobulins, 2010.

, J. Allergy Clin. Immunol, vol.125, pp.41-52

M. Schwemmle, M. J. Clemens, K. Hilse, K. Pfeifer, H. Tröster et al., Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells, Proc. Natl. Acad. Sci. U. S. A, vol.89, pp.10292-10296, 1992.

M. L. Scimone, I. Aifantis, I. Apostolou, H. Von-boehmer, and U. H. Von-andrian, A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.7006-7011, 2006.

E. Sebzda, S. Mariathasan, T. Ohteki, R. Jones, M. F. Bachmann et al., Selection of the T cell repertoire, Annu. Rev. Immunol, vol.17, pp.829-874, 1999.

J. R. Seehafer, N. C. Goldberg, C. H. Dicken, and W. P. Su, Cutaneous manifestations of angioimmunoblastic lymphadenopathy, Arch. Dermatol, vol.116, pp.41-45, 1980.

E. Seto, A. Moosmann, S. Grömminger, N. Walz, A. Grundhoff et al., Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells, PLoS Pathog, vol.6, p.1001063, 2010.

K. H. Shair, K. M. Bendt, R. H. Edwards, E. C. Bedford, J. N. Nielsen et al., EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas, 2007.
DOI : 10.1371/journal.ppat.0030166
URL : https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.0030166&type=printable

R. Shaknovich, K. Basso, G. Bhagat, M. Mansukhani, G. Hatzivassiliou et al., Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic posttransplant lymphoproliferative disorders and the signature of viral signaling, Haematologica, vol.91, pp.1313-1320, 2006.

C. Shannon-lowe, R. , and M. , Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection, PLoS Pathog, vol.7, 2011.

C. D. Shannon-lowe, B. Neuhierl, G. Baldwin, A. B. Rickinson, and H. Delecluse,

, Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.7065-7070

T. V. Sharp, M. Schwemmle, I. Jeffrey, K. Laing, H. Mellor et al., Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA, Nucleic Acids Res, vol.21, pp.4483-4490, 1993.

Y. Shen, S. Zhang, R. Sun, T. Wu, and J. Qian, Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients, Emerg. Microbes Infect, vol.4, p.20, 2015.

D. Shibata and L. M. Weiss, Epstein-Barr virus-associated gastric adenocarcinoma, Am. J. Pathol, vol.140, pp.769-774, 1992.

D. Shibata, M. Tokunaga, Y. Uemura, E. Sato, S. Tanaka et al., , 1991.

, Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma, Am. J. Pathol, vol.139, pp.469-474

Y. Shibata, Y. Hoshino, S. Hara, H. Yagasaki, S. Kojima et al., Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection, J. Med. Virol, vol.78, pp.770-779, 2006.

Y. Shinkai, G. Rathbun, K. P. Lam, E. M. Oltz, V. Stewart et al., RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement, Cell, vol.68, pp.855-867, 1992.

K. Shire, P. Kapoor, K. Jiang, M. N. Hing, N. Sivachandran et al., Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation, J. Virol, vol.80, pp.5261-5272, 2006.

A. Simon, M. Peoch, P. Casassus, E. Deconinck, P. Colombat et al., Upfront VIP-reinforcedABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95, Br. J. Haematol, vol.151, pp.159-166, 2010.

A. J. Sinclair, I. Palmero, G. Peters, and P. J. Farrell, EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus, EMBO J, vol.13, pp.3321-3328, 1994.

A. Singer, S. Adoro, and J. Park, Lineage fate and intense debate: myths, models and mechanisms of CD4-versus CD8-lineage choice, Nat. Rev. Immunol, vol.8, pp.788-801, 2008.

N. Sivachandran, F. Sarkari, and L. Frappier, Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies, PLoS Pathog, vol.4, p.1000170, 2008.

N. Sivachandran, C. W. Dawson, L. S. Young, F. Liu, J. Middeldorp et al., Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma, J. Virol, vol.86, pp.60-68, 2012.

J. W. Sixbey and Q. Y. Yao, Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism, Science, vol.255, pp.1578-1580, 1992.

J. W. Sixbey, P. Shirley, P. J. Chesney, D. M. Buntin, and L. Resnick, Detection of a second widespread strain of Epstein-Barr virus, Lancet Lond. Engl, vol.2, pp.761-765, 1989.

J. L. Smith, E. Hodges, C. T. Quin, K. P. Mccarthy, W. et al., Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy, Am. J. Pathol, vol.156, pp.661-669, 2000.

P. R. Smith, O. De-jesus, D. Turner, M. Hollyoake, C. E. Karstegl et al., Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus, J. Virol, vol.74, pp.3082-3092, 2000.

C. L. Sokol, N. Chu, S. Yu, S. A. Nish, T. M. Laufer et al., , 2009.

, Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response, Nat. Immunol, vol.10, pp.713-720

V. Soni, E. Cahir-mcfarland, and E. Kieff, LMP1 TRAFficking activates growth and survival pathways, Adv. Exp. Med. Biol, vol.597, pp.173-187, 2007.

R. Sonnen, W. Schmidt, H. K. Müller-hermelink, and N. Schmitz, The International Prognostic Index determines the outcome of patients with nodal mature T-cell lymphomas, Br. J. Haematol, vol.129, pp.366-372, 2005.

A. G. Stansfeld, J. Diebold, H. Noel, Y. Kapanci, F. Rilke et al., Updated Kiel classification for lymphomas, Lancet Lond. Engl, vol.1, pp.292-293, 1988.

L. D. Strockbine, J. I. Cohen, T. Farrah, S. D. Lyman, F. Wagener et al.,

R. J. Armitage and M. K. Spriggs, The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor, J. Virol, vol.72, pp.4015-4021, 1998.

J. Styczynski, H. Einsele, L. Gil, and P. Ljungman, Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases, Transpl. Infect. Dis. Off. J. Transplant. Soc, vol.11, pp.383-392, 2009.

Y. Sugawara, Y. Mizugaki, T. Uchida, T. Torii, S. Imai et al., Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression, Virology, vol.256, pp.196-202, 1999.

M. Sugiura, S. Imai, M. Tokunaga, S. Koizumi, M. Uchizawa et al., Transcriptional analysis of Epstein-Barr virus gene expression in EBVpositive gastric carcinoma: unique viral latency in the tumour cells, Br. J. Cancer, vol.74, pp.625-631, 1996.

Z. Sun, Z. Liu, S. Liu, X. Sun, Z. Luo et al., Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China, PloS One, vol.10, p.140529, 2015.

R. Suzuki, Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma, Semin. Hematol, vol.51, pp.42-51, 2014.

S. H. Swerdlow, E. Campo, S. A. Pileri, N. L. Harris, H. Stein et al., The 2016 revision of the World Health Organization classification of lymphoid neoplasms, J. Immunol. Baltim. Md, vol.127, pp.5993-5998, 1950.
URL : https://hal.archives-ouvertes.fr/hal-01800015

E. Tagliavini, G. Rossi, R. Valli, M. Zanelli, A. Cadioli et al., Lymphomatoid granulomatosis: a practical review for pathologists dealing with this rare pulmonary lymphoproliferative process, Pathologica, vol.105, pp.111-116, 2013.

K. Takada and Y. Ono, Synchronous and sequential activation of latently infected Epstein-Barr virus genomes, J. Virol, vol.63, pp.445-449, 1989.

T. Takakuwa, W. Luo, M. F. Ham, N. Wada, A. et al., Identification of Epstein-Barr virus integrated sites in lymphoblastoid cell line (IB4), Virus Res, vol.108, pp.133-138, 2005.

H. Takeshita, T. Yoshizaki, W. E. Miller, H. Sato, M. Furukawa et al., Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2, J. Virol, vol.73, pp.5548-5555, 1999.

H. Takeuchi, R. Kobayashi, M. Hasegawa, and K. Hirai, Detection of latent, 1997.

. Epstein-barr, virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR, Arch. Virol, vol.142, pp.1743-1756

B. T. Tan, R. A. Warnke, and D. A. Arber, The frequency of B-and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations, J. Mol. Diagn. JMD, vol.8, pp.466-475, 2006.

S. G. Tangye, U. Palendira, and E. S. Edwards, Human immunity against EBV-lessons from the clinic, J. Exp. Med, vol.214, pp.269-283, 2017.

J. Tanner, J. Weis, D. Fearon, Y. Whang, and E. Kieff, Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis, Cell, vol.50, pp.203-213, 1987.

Q. Tao, K. D. Robertson, A. Manns, A. Hildesheim, and R. F. Ambinder, , 1998.

. Epstein-barr, virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue, Blood, vol.91, pp.1373-1381

E. Tchernonog, P. Faurie, P. Coppo, H. Monjanel, A. Bonnet et al.,

M. Mercier, J. Dupuis, F. Bijou, and C. Herbaux, Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.28, pp.843-848, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01529409

I. Tempera, A. De-leo, A. V. Kossenkov, M. Cesaroni, H. Song et al., Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBVInfected B-Lymphocyte Survival, J. Virol, vol.90, pp.345-355, 2015.

R. Thomas, K. F. Macsween, K. Mcaulay, D. Clutterbuck, R. Anderson et al.,

C. D. Higgins, A. J. Swerdlow, N. Harrison, and H. Williams, Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions, J. Med. Virol, vol.78, pp.1204-1209, 2006.

D. A. Thorley-lawson, EBV Persistence-Introducing the Virus, 2015.

, Microbiol. Immunol, vol.390, pp.151-209

D. A. Thorley-lawson, K. A. Duca, and M. Shapiro, Epstein-Barr virus: a paradigm for persistent infection-for real and in virtual reality, Trends Immunol, vol.29, pp.195-201, 2008.

H. Tilly, E. Lepage, B. Coiffier, M. Blanc, R. Herbrecht et al., Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma, Blood, vol.102, pp.4284-4289, 2003.

K. Tobinai, K. Minato, T. Ohtsu, K. Mukai, Y. Kagami et al., Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma, Blood, vol.72, pp.1000-1006, 1988.

B. Tomkinson, E. Robertson, and E. Kieff, Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation, J. Virol, vol.67, pp.2014-2025, 1993.

C. Tripodo, G. Gri, P. P. Piccaluga, B. Frossi, C. Guarnotta et al., Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma, Am. J. Pathol, vol.177, pp.792-802, 2010.

S. Tsao, C. M. Tsang, K. To, and K. Lo, The role of Epstein-Barr virus in epithelial malignancies, J. Pathol, vol.235, pp.323-333, 2015.

C. D. Tsoukas and J. D. Lambris, Expression of CR2/EBV receptors on human thymocytes detected by monoclonal antibodies, Eur. J. Immunol, vol.18, pp.1299-1302, 1988.

T. Tsurumi, M. Fujita, and A. Kudoh, Latent and lytic Epstein-Barr virus replication strategies, Rev. Med. Virol, vol.15, pp.3-15, 2005.

S. M. Tugizov, J. W. Berline, and J. M. Palefsky, Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells, Nat. Med, vol.9, pp.307-314, 2003.

S. Tzellos and P. Farrell, Epstein-Barr virus sequence variation-biology and disease, Pathogens, vol.1, pp.156-174, 2012.

J. Uchida, T. Yasui, Y. Takaoka-shichijo, M. Muraoka, W. Kulwichit et al., Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses, Science, vol.286, pp.300-303, 1999.

T. Usui, R. Nishikomori, A. Kitani, W. Strober, R. Valentine et al., GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or Tbet, Immunity, vol.18, pp.415-428, 2003.

J. Shao, J. R. Arrand, and L. S. Young, Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation, Mol. Cancer, vol.9, p.1, 2010.

A. Valera, O. Balagué, L. Colomo, A. Martínez, J. Delabie et al., IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas, Am. J. Surg. Pathol, vol.34, pp.1686-1694, 2010.

D. Vallois, M. P. Dobay, R. D. Morin, F. Lemonnier, E. Missiaglia et al., Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cellderived lymphomas, Blood, vol.128, pp.1490-1502, 2016.

M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, , 2006.

, TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells, Immunity, vol.24, pp.179-189

D. T. Vereide, E. Seto, Y. Chiu, M. Hayes, T. Tagawa et al., Epstein-Barr virus maintains lymphomas via its miRNAs, Oncogene, vol.33, pp.1258-1264, 2014.

R. J. Verhoeven, S. Tong, G. Zhang, J. Zong, Y. Chen et al., The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's ReedSternberg-like phenotype, J. Pathol, vol.90, pp.83-92, 2008.

M. Vockerodt, L. Yap, C. Shannon-lowe, H. Curley, W. Wei et al., The Epstein-Barr virus and the pathogenesis of lymphoma, J. Pathol, vol.235, pp.312-322, 2015.

J. M. Vose, Peripheral T-cell non-Hodgkin's lymphoma, Hematol. Oncol. Clin. North Am, vol.22, pp.997-1005, 2008.

J. Vose, J. Armitage, and D. Weisenburger, International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, 2008.

D. M. Walling, C. M. Flaitz, C. M. Nichols, S. D. Hudnall, and K. Adler-storthz, , 2001.

, Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo, J. Infect. Dis, vol.184, pp.1499-1507

D. Wang, D. Liebowitz, and E. Kieff, An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells, Cell, vol.43, pp.831-840, 1985.

F. Wang, S. F. Tsang, M. G. Kurilla, J. I. Cohen, and E. Kieff, Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1, J. Virol, vol.64, pp.3407-3416, 1990.

F. Wang, W. Chen, P. Liu, J. Zhou, B. Liu et al., , 2017.

, Lentivirus-mediated RNAi knockdown of LMP2A inhibits the growth of the Epstein-Barrassociated gastric carcinoma cell line GT38 in vitro, Exp. Ther. Med, vol.13, pp.187-193

K. Wang, S. T. Yuen, J. Xu, S. P. Lee, H. H. Yan et al., Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer, Nat. Genet, vol.46, pp.573-582, 2014.

D. Watry, J. A. Hedrick, S. Siervo, G. Rhodes, J. J. Lamberti et al., Infection of human thymocytes by Epstein-Barr virus, J. Exp. Med, vol.173, pp.971-980, 1991.

J. M. Weiss, A. M. Bilate, M. Gobert, Y. Ding, M. A. Curotto-de-lafaille et al., Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells, J. Exp. Med, vol.209, p.1, 2012.

L. M. Weiss, J. G. Strickler, R. F. Dorfman, S. J. Horning, R. A. Warnke et al., Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma, Am. J. Pathol, vol.122, pp.392-397, 1986.

L. M. Weiss, J. G. Strickler, R. A. Warnke, D. T. Purtilo, and J. Sklar, EpsteinBarr viral DNA in tissues of Hodgkin's disease, Am. J. Pathol, vol.129, pp.86-91, 1987.

L. M. Weiss, E. S. Jaffe, X. F. Liu, Y. Y. Chen, D. Shibata et al., , 1992.

, Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma, Blood, vol.79, pp.1789-1795

D. Widney, W. J. Boscardin, A. Kasravi, and O. Martínez-maza, Expression and function of CD28 on Epstein-Barr virus-positive B cell lines and AIDS-associated nonHodgkin's lymphoma cell lines, Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med, vol.24, pp.82-93, 2003.

K. Willenbrock, A. Bräuninger, and M. Hansmann, Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases, Br. J. Haematol, vol.138, pp.733-739, 2007.

H. Williams, K. Macsween, K. Mcaulay, C. Higgins, N. Harrison et al., Analysis of immune activation and clinical events in acute infectious mononucleosis, J. Infect. Dis, vol.190, pp.63-71, 2004.

G. Winberg, L. Matskova, F. Chen, P. Plant, D. Rotin et al., Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases, Mol. Cell. Biol, vol.20, pp.8526-8535, 2000.

C. M. Witt, S. Raychaudhuri, B. Schaefer, A. K. Chakraborty, and E. A. Robey, , 2005.

V. H. Wood, J. D. O&apos;neil, W. Wei, S. E. Stewart, C. W. Dawson et al., Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways, PLoS Biol, vol.3, pp.4135-4147, 2007.

H. Wu, P. Kapoor, L. Frappier, J. Xiao, J. M. Palefsky et al., Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1, J. Virol, vol.76, pp.430-442, 2002.

J. Xiao, J. M. Palefsky, R. Herrera, J. Berline, and S. M. Tugizov, EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells, Virology, vol.388, pp.335-343, 2009.

P. Xie, Z. J. Kraus, L. L. Stunz, and G. A. Bishop, Roles of TRAF molecules in B lymphocyte function, Cytokine Growth Factor Rev, vol.19, pp.199-207, 2008.

Y. Xie, Y. Wu, X. Zhou, M. Yao, S. Ning et al., Association of polymorphisms hOGGI rs1052133 and hMUTYH rs3219472 with risk of nasopharyngeal carcinoma in a Chinese population, OncoTargets Ther, vol.9, pp.755-760, 2016.

B. Xu, P. Liu, N. Yamamoto, T. Takizawa, Y. Iwanaga et al., No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases, PloS One, vol.9, 2000.

, Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs, FEBS Lett, vol.484, pp.153-158

L. Yang, K. Aozasa, K. Oshimi, and K. Takada, Epstein-Barr virus (EBV)encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction, Cancer Res, vol.64, pp.5332-5337, 2004.

T. Yasui, M. Luftig, V. Soni, and E. Kieff, Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.278-283, 2004.

J. Yates, N. Warren, D. Reisman, and B. Sugden, A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells, Proc. Natl. Acad. Sci. U. S. A, vol.81, pp.3806-3810, 1984.

A. Yokoyama, M. Tanaka, G. Matsuda, K. Kato, M. Kanamori et al., Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation, J. Virol, vol.75, pp.5119-5128, 2001.

H. Y. Yoo, P. Kim, W. S. Kim, S. H. Lee, S. Kim et al., Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, Haematologica, vol.101, pp.757-763, 2016.

L. S. Young, M. , and P. G. , Epstein-Barr virus and oncogenesis: from latent genes to tumours, Oncogene, vol.22, pp.5108-5121, 2003.

L. S. Young and A. B. Rickinson, Epstein-Barr virus: 40 years on, Nat. Rev. Cancer, vol.4, pp.757-768, 2004.

L. Young, C. Alfieri, K. Hennessy, H. Evans, C. O&apos;hara et al., Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease, N. Engl. J. Med, vol.321, pp.1080-1085, 1989.

L. S. Young, R. Lau, M. Rowe, G. Niedobitek, G. Packham et al., Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia, J. Virol, vol.65, pp.2868-2874, 1991.

A. Zettl, S. Lee, T. Rüdiger, P. Starostik, M. Marino et al., Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, Am. J. Clin. Pathol, vol.117, pp.368-379, 2002.

Q. Zhang, L. Brooks, P. Busson, F. Wang, D. Charron et al., Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line, Eur. J. Immunol, vol.24, pp.1467-1470, 1994.

T. Zhang, Q. Fu, D. Gao, L. Ge, L. Sun et al., EBV associated lymphomas in 2008 WHO classification, Pathol. Res. Pract, vol.210, pp.69-73, 2014.

L. Zhou, M. M. Chong, and D. R. Littman, Plasticity of CD4+ T cell lineage differentiation, Immunity, vol.30, pp.646-655, 2009.

Y. Zhou, A. D. Attygalle, S. Chuang, T. Diss, H. Ye et al., Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load, Br. J. Haematol, vol.138, pp.44-53, 2007.

J. Zhu, D. Jankovic, A. Grinberg, L. Guo, P. et al., Gfi-1 plays an important role in IL-2-mediated Th2 cell expansion, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.18214-18219, 2006.

U. Zimber, H. K. Adldinger, G. M. Lenoir, M. Vuillaume, M. V. Knebel-doeberitz et al., Geographical prevalence of two types of Epstein-Barr virus, Virology, vol.154, pp.56-66, 1986.

U. Zimber-strobl and L. J. Strobl, EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes, Semin. Cancer Biol, vol.11, pp.423-434, 2001.

U. Zimber-strobl, K. O. Suentzenich, G. Laux, D. Eick, M. Cordier et al., Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene, J. Virol, vol.65, pp.415-423, 1991.

U. Zimber-strobl, L. J. Strobl, C. Meitinger, R. Hinrichs, T. Sakai et al., Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless, EMBO J, vol.13, pp.4973-4982, 1994.

D. Zotos, J. M. Coquet, Y. Zhang, A. Light, K. Costa et al., IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism, J. Exp. Med, vol.207, pp.365-378, 2010.

. Van-dongen, Amorces utilisées pour l'amplification des réarrangements de l'Ig A) Amorces utilisées pour l'amplification des réarrangements VH-JH de la chaine lourde Modifié d'après, 2003.

. Van-dongen, B) Amorces utilisées pour l'amplification des réarrangements V k-J k de la chaine légère. Modifié d'après, 2003.